Structures by: Thakuria R.
Total: 101
C20H18N6
C20H18N6
Organic & biomolecular chemistry (2020) 18, 33 6514-6518
a=5.8660(5)Å b=8.1481(8)Å c=18.3926(18)Å
α=90° β=90° γ=90°
Isoniazid-D-tartaric acid salt
C20H26N6O14
Chemical Communications (2019)
a=7.8533(2)Å b=15.1576(4)Å c=19.7612(5)Å
α=90° β=90° γ=90°
Isoniazid-D-tartaric acid salt
C20H13N6O14
Chemical Communications (2019)
a=7.8825(5)Å b=15.1865(9)Å c=19.8838(11)Å
α=90° β=90° γ=90°
Isoniazid-DL-tartaric acid salt
C10H13N3O7
Chemical Communications (2019)
a=12.409(2)Å b=7.1753(14)Å c=14.653(3)Å
α=90° β=113.098(10)° γ=90°
1,4-di(bis(4'-hydroxyphenyl)methyl)benzene dimethylsulfoxide solvate
C32H26O4,2(C2H6OS)
New Journal of Chemistry (2010) 34, 4 623
a=11.0387(11)Å b=7.4017(7)Å c=19.4980(19)Å
α=90.00° β=96.343(2)° γ=90.00°
1,4-di(bis(4'-hydroxyphenyl)methyl)benzene ethylacetate solvate
C32H26O4,2(C4H8O2)
New Journal of Chemistry (2010) 34, 4 623
a=7.3791(5)Å b=10.4359(8)Å c=11.3692(8)Å
α=93.3570(10)° β=95.2410(10)° γ=100.8240(10)°
1,4-di(bis(4'-hydroxyphenyl)methyl)benzene isopropanol solvate
C32H26O4,4(C3H8O)
New Journal of Chemistry (2010) 34, 4 623
a=33.506(3)Å b=5.8797(4)Å c=22.036(2)Å
α=90.00° β=115.061(2)° γ=90.00°
1:1.5 complex of 1,4-di(bis(4'-hydroxyphenyl)methyl)benzene and Phenazine
C32H26O4,1.5(C12H8N2)
New Journal of Chemistry (2010) 34, 4 623
a=10.2976(8)Å b=11.2084(9)Å c=18.4225(15)Å
α=96.0410(10)° β=103.7210(10)° γ=102.7000(10)°
1:2 complex of 1,4-di(bis(4'-hydroxyphenyl)methyl)benzene and N,N'-pyrazinedioxide
C32H26O4,2(C4H4N2O2)
New Journal of Chemistry (2010) 34, 4 623
a=13.064(2)Å b=7.6296(11)Å c=16.929(3)Å
α=90.00° β=99.722(2)° γ=90.00°
1,4-di(bis(3'-hydroxy,2'-,4'-dimethoxyphenyl)methyl)benzene dioxane solvate
C40H42O12,2(C4H8O2)
New Journal of Chemistry (2010) 34, 4 623
a=9.039(4)Å b=10.605(4)Å c=13.461(6)Å
α=101.940(7)° β=98.428(8)° γ=112.198(7)°
1,4-di(bis(4'-hydroxy 3'-methylphenyl)methyl)benzene dimethylformamide solvate
C36H34O4,2(C3H7NO)
New Journal of Chemistry (2010) 34, 4 623
a=23.799(2)Å b=8.0974(8)Å c=18.3595(15)Å
α=90.00° β=113.226(5)° γ=90.00°
1,4-di(bis(4'-hydroxy 3'-methylphenyl)methyl)benzene nitromethane solvate
C36H34O4,2(CH3NO2)
New Journal of Chemistry (2010) 34, 4 623
a=5.5173(5)Å b=12.0094(12)Å c=12.9806(13)Å
α=91.144(2)° β=96.446(2)° γ=91.410(2)°
1,4-di(bis(4'-hydroxy 3',5'-dimethylphenyl)methyl)benzene dimethylsulfoxaide solvate
C40H42O4,2(C2H6OS)
New Journal of Chemistry (2010) 34, 4 623
a=11.340(2)Å b=8.2249(15)Å c=21.892(4)Å
α=90.00° β=102.049(4)° γ=90.00°
1,4-di(bis(4'-hydroxy 3',5'-dimethylphenyl)methyl)benzene toluene solvate
C40H42O4,C7H8
New Journal of Chemistry (2010) 34, 4 623
a=8.7313(7)Å b=10.2761(9)Å c=11.4745(10)Å
α=64.9820(10)° β=75.9800(10)° γ=86.5800(10)°
1:2 complex of 1,4-di(bis(4'-hydroxyphenyl)methyl)benzene and 4,4'-bipyridine-N,N'-dioxide
C32H26O4,2(C10H8N2O2)
New Journal of Chemistry (2010) 34, 4 623
a=20.631(4)Å b=7.1465(14)Å c=28.309(5)Å
α=90.00° β=90.00° γ=90.00°
1:2 complex of 1,4-di(bis(4'-hydroxyphenyl)methyl)benzene and quinoxaline
C32H26O4,2(C8H6N2)
New Journal of Chemistry (2010) 34, 4 623
a=14.472(6)Å b=16.115(6)Å c=8.057(3)Å
α=90.00° β=93.044(7)° γ=90.00°
1,4-di(bis(3'-hydroxy,2'-,4'-dimethoxyphenyl)methyl)benzene dimethylsulfoxide solvate
C40H42O12,2(C2H6OS)
New Journal of Chemistry (2010) 34, 4 623
a=10.8550(7)Å b=14.2040(9)Å c=14.8984(9)Å
α=90.00° β=111.1700(10)° γ=90.00°
1,4-di(bis(4'-hydroxy 3',5'-dimethylphenyl)methyl)benzene
C40H42O4
New Journal of Chemistry (2010) 34, 4 623
a=15.0090(17)Å b=5.5072(6)Å c=18.887(2)Å
α=90.00° β=104.850(2)° γ=90.00°
C22H24N6O2S
C22H24N6O2S
CrystEngComm (2020) 22, 6 1120-1130
a=9.1672(4)Å b=9.2117(5)Å c=14.8900(8)Å
α=86.026(3)° β=72.591(2)° γ=65.538(2)°
C24H26N4O5S
C24H26N4O5S
CrystEngComm (2020) 22, 6 1120-1130
a=9.5404(7)Å b=13.9656(9)Å c=18.1238(12)Å
α=90° β=102.142(3)° γ=90°
C24H30N4O7S
C24H30N4O7S
CrystEngComm (2020) 22, 6 1120-1130
a=11.9730(5)Å b=18.2134(7)Å c=11.9964(4)Å
α=90° β=96.699(2)° γ=90°
C28H32N4O9S
C28H32N4O9S
CrystEngComm (2020) 22, 6 1120-1130
a=9.9166(10)Å b=13.3673(14)Å c=23.035(2)Å
α=90° β=97.163(5)° γ=90°
C11H10N4O,(H2O)
C11H10N4O,(H2O)
CrystEngComm (2008) 10, 12 1735
a=7.0172(14)Å b=10.343(2)Å c=15.516(3)Å
α=90.00° β=90.00° γ=90.00°
Cis,cis-1,3,5-cyclohexanetricarboxylic acid - (4(3H)- pyrimidone)2
(C9H12O6),2(C4H4N2O)
CrystEngComm (2008) 10, 12 1735
a=13.3218(14)Å b=5.7554(6)Å c=24.093(3)Å
α=90.00° β=90.508(2)° γ=90.00°
(C24H20AgCl2N6O2),(C2H3N),(NO3)
(C24H20AgCl2N6O2),(C2H3N),(NO3)
CrystEngComm (2008) 10, 12 1891
a=9.3502(6)Å b=12.0861(8)Å c=13.0114(8)Å
α=85.5080(10)° β=80.5210(10)° γ=72.6230(10)°
(C24H20AgBr2N6O2),(C2H3N),(NO3)
(C24H20AgBr2N6O2),(C2H3N),(NO3)
CrystEngComm (2008) 10, 12 1891
a=9.5477(5)Å b=12.3303(6)Å c=12.8922(7)Å
α=84.5970(10)° β=79.3760(10)° γ=71.7090(10)°
(C24H20AgF2N6O2),(C2H3N),(NO3)
(C24H20AgF2N6O2),(C2H3N),(NO3)
CrystEngComm (2008) 10, 12 1891
a=10.3793(9)Å b=11.5395(10)Å c=12.4980(11)Å
α=95.3540(10)° β=101.5830(10)° γ=112.4090(10)°
(C48H40Ag2I4N12O4),2(C2H3N),2(NO3)
(C48H40Ag2I4N12O4),2(C2H3N),2(NO3)
CrystEngComm (2008) 10, 12 1891
a=13.2760(10)Å b=15.0546(12)Å c=17.5415(14)Å
α=107.8060(10)° β=105.0930(10)° γ=106.9840(10)°
2(C26H23Ag1F2N7O2),(C2H3N),2(NO3)
2(C26H23Ag1F2N7O2),(C2H3N),2(NO3)
CrystEngComm (2008) 10, 12 1891
a=16.6486(16)Å b=10.3266(10)Å c=32.967(3)Å
α=90.00° β=90.225(2)° γ=90.00°
(C26H25AgN7O2)(C24H22AgN6O2)2(NO3)
(C26H25AgN7O2)(C24H22AgN6O2)2(NO3)
CrystEngComm (2008) 10, 12 1891
a=19.4555(12)Å b=25.7212(16)Å c=10.2172(6)Å
α=90.00° β=102.6250(10)° γ=90.00°
0.5(C48H40Ag2Br2.18I1.82N12O4),C2H3N,NO3
0.5(C48H40Ag2Br2.18I1.82N12O4),C2H3N,NO3
CrystEngComm (2008) 10, 12 1891
a=9.7667(17)Å b=12.505(2)Å c=12.752(2)Å
α=83.684(3)° β=78.689(3)° γ=70.921(2)°
0.5(C48H40Ag2Br2.92I1.08N12O4),C2H3N,NO3
0.5(C48H40Ag2Br2.92I1.08N12O4),C2H3N,NO3
CrystEngComm (2008) 10, 12 1891
a=9.6987(7)Å b=12.4579(9)Å c=12.7686(9)Å
α=84.0100(10)° β=78.7800(10)° γ=71.0240(10)°
0.5(C48H40Ag2Br3.88I0.12N12O4),C2H3N,NO3
0.5(C48H40Ag2Br3.88I0.12N12O4),C2H3N,NO3
CrystEngComm (2008) 10, 12 1891
a=9.5811(9)Å b=12.3598(12)Å c=12.8807(13)Å
α=84.463(2)° β=79.304(2)° γ=71.599(2)°
C21H23N3O4
C21H23N3O4
CrystEngComm (2011) 13, 9 3232
a=8.930(3)Å b=9.877(3)Å c=22.497(6)Å
α=90.00° β=90.00° γ=90.00°
C20H24N3O2
C20H24N3O2
CrystEngComm (2011) 13, 9 3232
a=10.631(9)Å b=9.315(8)Å c=18.052(15)Å
α=90.00° β=103.771(13)° γ=90.00°
C21H25N3O5
C21H25N3O5
CrystEngComm (2011) 13, 9 3232
a=25.244(4)Å b=18.525(3)Å c=8.9052(13)Å
α=90.00° β=102.753(3)° γ=90.00°
C17H27Cl2N3O3
C17H27Cl2N3O3
CrystEngComm (2011) 13, 9 3232
a=8.539(3)Å b=13.703(4)Å c=17.468(5)Å
α=90.00° β=103.311(5)° γ=90.00°
C24H25N3O3
C24H25N3O3
CrystEngComm (2011) 13, 9 3232
a=13.941(8)Å b=15.599(9)Å c=9.412(5)Å
α=90.00° β=99.499(11)° γ=90.00°
C17H20N3O0.5
C17H20N3O0.5
CrystEngComm (2011) 13, 9 3232
a=9.801(3)Å b=17.308(5)Å c=9.009(2)Å
α=90.00° β=106.000(4)° γ=90.00°
C17H20N3O0.5
C17H20N3O0.5
CrystEngComm (2011) 13, 9 3232
a=9.801(3)Å b=17.308(5)Å c=9.009(2)Å
α=90.00° β=106.000(4)° γ=90.00°
C23H33ClFN3O
C23H33ClFN3O
CrystEngComm (2012) 14, 7 2367
a=17.0708(14)Å b=11.9644(10)Å c=11.0576(9)Å
α=90.00° β=106.1890(10)° γ=90.00°
C23H31ClFN3
C23H31ClFN3
CrystEngComm (2012) 14, 7 2367
a=7.485(10)Å b=8.578(9)Å c=16.794(18)Å
α=82.718(17)° β=85.478(17)° γ=84.883(11)°
C27H28N4
C27H28N4
Organic & biomolecular chemistry (2020) 18, 33 6514-6518
a=13.786(5)Å b=13.940(5)Å c=12.043(5)Å
α=90° β=95.844(5)° γ=90°
1,4-di(bis(4'-hydroxyphenyl)methyl)benzene
C32H26O4
New Journal of Chemistry (2010) 34, 4 623
a=10.1926(10)Å b=11.0478(10)Å c=13.0960(14)Å
α=101.849(2)° β=102.082(2)° γ=115.675(2)°
C20H23N3O4
C20H23N3O4
CrystEngComm (2011) 13, 9 3232
a=10.3222(16)Å b=10.7865(17)Å c=10.8589(17)Å
α=111.053(2)° β=115.931(2)° γ=99.711(2)°
Ethenzamide-24Dihydroxybenzoic acid
C7H5O4,C9H11NO2
CrystEngComm (2017) 19, 5 826
a=9.6638(17)Å b=6.6901(11)Å c=24.670(4)Å
α=90° β=99.732(8)° γ=90°
Ethenzamide-35Dihydroxybenzoicacid dihydrate
C9H11NO2,3(C7H6O4),2(H2O)
CrystEngComm (2017) 19, 5 826
a=11.1756(12)Å b=11.7633(14)Å c=12.2009(14)Å
α=95.319(8)° β=102.434(7)° γ=100.852(7)°
Ethenzamide-35Dihydroxybenzoic acid
C9H11NO2,C7H6O4
CrystEngComm (2017) 19, 5 826
a=14.9229(8)Å b=18.9781(13)Å c=21.8605(14)Å
α=90° β=90° γ=90°
Ethenzamide Ferulic acid
C10H10O4,C9H11NO2
CrystEngComm (2017) 19, 5 826
a=15.539(2)Å b=7.4265(10)Å c=31.796(4)Å
α=90° β=90° γ=90°
C27H23La2N5O14
C27H23La2N5O14
CrystEngComm (2014) 16, 24 5244
a=8.1241(3)Å b=30.3843(10)Å c=15.6616(5)Å
α=90° β=90° γ=90°
C27H23Ce2N5O14
C27H23Ce2N5O14
CrystEngComm (2014) 16, 24 5244
a=8.1162(4)Å b=30.2842(14)Å c=15.6709(7)Å
α=90.00° β=90.00° γ=90.00°
C24H14Br4Co2N4O9
C24H14Br4Co2N4O9
CrystEngComm (2014) 16, 24 5244
a=14.2109(5)Å b=17.6868(6)Å c=14.2110(5)Å
α=90.00° β=118.306(2)° γ=90.00°
C12H6Br2CdN2O4
C12H6Br2CdN2O4
CrystEngComm (2014) 16, 24 5244
a=12.0504(3)Å b=9.9837(2)Å c=24.8139(5)Å
α=90.00° β=101.2980(10)° γ=90.00°
C31H30Mn3N6O15
C31H30Mn3N6O15
CrystEngComm (2014) 16, 24 5244
a=13.2579(5)Å b=11.4380(3)Å c=28.7450(10)Å
α=90.00° β=99.887(2)° γ=90.00°
C11H12N2O5Zn,C4H9NO
C11H12N2O5Zn,C4H9NO
CrystEngComm (2014) 16, 24 5244
a=10.8285(4)Å b=11.1933(4)Å c=14.7990(6)Å
α=90.00° β=90.00° γ=90.00°
C27H23N5O14Sm2
C27H23N5O14Sm2
CrystEngComm (2014) 16, 24 5244
a=8.02340(10)Å b=30.2439(5)Å c=15.3280(2)Å
α=90.00° β=90.00° γ=90.00°
C15H21CdN3O6
C15H21CdN3O6
CrystEngComm (2014) 16, 24 5244
a=9.2879(3)Å b=11.9733(3)Å c=16.3513(5)Å
α=90.00° β=101.7090(16)° γ=90.00°
Chlorodimethyl sulfonylhydrazone
C21H19ClN2O2S
CrystEngComm (2014) 16, 22 4681
a=22.305(2)Å b=12.0112(12)Å c=15.3336(15)Å
α=90.00° β=100.953(2)° γ=90.00°
Chlorodimethyl sulfonylhydrazone
C21H19ClN2O2S
CrystEngComm (2014) 16, 22 4681
a=11.726(5)Å b=15.488(7)Å c=22.317(10)Å
α=90.00° β=90.00° γ=90.00°
Fluorodimethyl sulfonylhydrazone
C21H19FN2O2S
CrystEngComm (2014) 16, 22 4681
a=11.939(2)Å b=15.261(3)Å c=21.322(4)Å
α=90.00° β=90.00° γ=90.00°
Methyldiiodo sulfonylhydrazone
C20H16I2N2O2S
CrystEngComm (2014) 16, 22 4681
a=11.6335(16)Å b=11.6089(16)Å c=15.843(2)Å
α=90.00° β=96.670(2)° γ=90.00°
Trichloro sulfonylhydrazone
C19H13Cl3N2O2S
CrystEngComm (2014) 16, 22 4681
a=22.655(4)Å b=11.6004(18)Å c=15.428(3)Å
α=90.00° β=101.926(3)° γ=90.00°
Olanzapine-Maleic acid 1:1
C17H21N4S,C4H3O4
CrystEngComm (2011) 13, 6 1759
a=10.852(5)Å b=13.748(7)Å c=13.879(7)Å
α=90.00° β=97.856(8)° γ=90.00°
Olanzapine-Maleic acid 1:2
C17H22N4S,2(C4H3O4)
CrystEngComm (2011) 13, 6 1759
a=8.518(3)Å b=9.804(4)Å c=16.210(6)Å
α=95.956(7)° β=97.945(7)° γ=107.789(7)°
C16H10N2
C16H10N2
Acta Crystallographica Section B (2019) 75, 5
a=24.316(6)Å b=3.9011(10)Å c=25.297(7)Å
α=90° β=90° γ=90°
C18H15NO2
C18H15NO2
Acta Crystallographica Section B (2019) 75, 5
a=7.7437(5)Å b=12.8797(9)Å c=16.2007(11)Å
α=108.298(3)° β=102.962(3)° γ=94.992(4)°
C19H16O4
C19H16O4
Acta Crystallographica Section B (2019) 75, 5
a=9.221(2)Å b=9.847(2)Å c=34.947(6)Å
α=90° β=90° γ=90°
C7H6O4,C5H5N3O
C7H6O4,C5H5N3O
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 1007-1016
a=7.7759(8)Å b=6.7421(6)Å c=23.996(2)Å
α=90° β=95.224(6)° γ=90°
C7H6O4,C5H5N3O
C7H6O4,C5H5N3O
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 1007-1016
a=10.0839(15)Å b=5.0936(8)Å c=23.335(3)Å
α=90° β=99.605(8)° γ=90°
C7H6O4,C5H5N3O
C7H6O4,C5H5N3O
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 1007-1016
a=5.0262(3)Å b=25.2701(11)Å c=9.7106(5)Å
α=90° β=97.492(3)° γ=90°
C7H7O3S,C5H6N3O
C7H7O3S,C5H6N3O
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 1007-1016
a=7.6458(9)Å b=9.9985(11)Å c=18.027(2)Å
α=103.727(5)° β=92.711(6)° γ=91.656(5)°
C10H10O4,C5H5N3O
C10H10O4,C5H5N3O
Acta crystallographica Section B, Structural science, crystal engineering and materials (2017) 73, Pt 5 1007-1016
a=7.4159(5)Å b=10.1690(7)Å c=11.0335(8)Å
α=70.471(3)° β=76.142(3)° γ=78.253(4)°
Olanzapine
C17H20N4S
Acta Crystallographica Section C (2011) 67, 11 o461-o463
a=9.9130(8)Å b=16.5329(13)Å c=9.9992(8)Å
α=90° β=98.0230(10)° γ=90°
C15H14N2O
C15H14N2O
ACS combinatorial science (2018) 20, 3 164-171
a=15.722(2)Å b=5.7944(7)Å c=13.6813(17)Å
α=90° β=100.711(5)° γ=90°
C34H32N2O8
C34H32N2O8
Crystal Growth & Design (2008) 8, 5 1471
a=14.959(3)Å b=9.0758(16)Å c=22.131(4)Å
α=90.00° β=90.00° γ=90.00°
C34H32N2O8
C34H32N2O8
Crystal Growth & Design (2008) 8, 5 1471
a=5.2770(9)Å b=16.174(3)Å c=18.145(3)Å
α=90.00° β=95.934(3)° γ=90.00°
C42H44Cl6O4
C42H44Cl6O4
Crystal Growth & Design (2008) 8, 5 1471
a=9.992(2)Å b=18.203(4)Å c=12.043(2)Å
α=90.00° β=108.20(3)° γ=90.00°
C42H48N2O8
C42H48N2O8
Crystal Growth & Design (2008) 8, 5 1471
a=5.2432(7)Å b=12.1351(16)Å c=14.5958(18)Å
α=79.407(2)° β=79.795(2)° γ=86.917(2)°
C5H5N3O
C5H5N3O
Crystal Growth & Design (2010) 10, 9 3931
a=14.315(2)Å b=3.6238(5)Å c=10.6158(15)Å
α=90.00° β=101.119(2)° γ=90.00°
C5H5N3O
C5H5N3O
Crystal Growth & Design (2010) 10, 9 3931
a=7.170(3)Å b=3.6477(15)Å c=10.648(4)Å
α=90.00° β=106.350(6)° γ=90.00°
C5H5N3O
C5H5N3O
Crystal Growth & Design (2010) 10, 9 3931
a=7.1756(14)Å b=3.6508(7)Å c=10.663(2)Å
α=90.00° β=106.337(3)° γ=90.00°
Pyrogallol
C6H6O3
Crystal Growth & Design (2012) 12, 8 3944
a=12.1144(11)Å b=3.7765(3)Å c=13.1365(12)Å
α=90.00° β=115.4840(10)° γ=90.00°
1:1 complex of pyrogallol and pyrazinamide
C6H6O3,C5H5N3O
Crystal Growth & Design (2012) 12, 8 3944
a=6.687(9)Å b=7.074(9)Å c=11.721(16)Å
α=80.61(2)° β=87.92(2)° γ=76.02(2)°
2:4 complex of pyrogallol and isonicotinamide
C6H6O3,2(C6H6N2O)
Crystal Growth & Design (2012) 12, 8 3944
a=17.056(2)Å b=5.8142(7)Å c=18.163(2)Å
α=90.00° β=100.886(2)° γ=90.00°
2:1 complex of pyrogallol and isonicotinamide
C6H6O3,0.5(C6H6N2O)
Crystal Growth & Design (2012) 12, 8 3944
a=9.2540(8)Å b=9.5435(9)Å c=10.0539(9)Å
α=72.4640(10)° β=83.730(2)° γ=80.0920(10)°
2:1 complex of pyrogallol and nicotinamide
C6H6O3,0.5(C6H6N2O)
Crystal Growth & Design (2012) 12, 8 3944
a=11.2860(13)Å b=19.551(2)Å c=7.8342(9)Å
α=90.00° β=108.082(2)° γ=90.00°
3:5 complex of pyrogallol and quinoline
3(C6H6O3),5(C9H7N)
Crystal Growth & Design (2012) 12, 8 3944
a=8.0271(16)Å b=16.182(3)Å c=20.306(4)Å
α=74.727(3)° β=86.151(4)° γ=85.632(4)°
2:3 complex of pyrogallol and quinoline
3(C9H7N),2(C6H6O3)
Crystal Growth & Design (2012) 12, 8 3944
a=7.5553(8)Å b=11.6292(13)Å c=18.763(2)Å
α=88.645(9)° β=80.688(9)° γ=76.572(10)°
1:2 complex of pyrogallol and 2 hydroxyquinoline
2(C9H7NO),C6H6O3
Crystal Growth & Design (2012) 12, 8 3944
a=7.6809(7)Å b=10.0076(9)Å c=13.4348(12)Å
α=73.3500(10)° β=82.756(2)° γ=84.385(2)°
1.5(C10H8N2),C6H6O3,H2O
1.5(C10H8N2),C6H6O3,H2O
Crystal Growth & Design (2012) 12, 8 3944
a=9.3257(10)Å b=9.5756(10)Å c=24.020(3)Å
α=91.162(2)° β=95.450(2)° γ=116.545(2)°
Pyrogallol 0.25 hydrate
C6H6O3,0.25(H2O)
Crystal Growth & Design (2012) 12, 8 3944
a=24.5039(12)Å b=24.5039(12)Å c=3.7849(4)Å
α=90.00° β=90.00° γ=90.00°
Olanzapinium hydrogenmalonate
C17H21N4S,C3H3O4
Crystal Growth & Design (2013) 13, 8 3672
a=9.1759(9)Å b=9.1769(9)Å c=13.6079(14)Å
α=92.146(2)° β=94.031(2)° γ=115.2640(10)°
Olanzapinium salicylate benzene
C33H35N4O3S
Crystal Growth & Design (2013) 13, 8 3672
a=9.270(4)Å b=10.539(5)Å c=15.713(7)Å
α=102.808(7)° β=104.176(8)° γ=95.930(8)°
Olanzapinium dimaleate monofumaric acid
C17H22N4S,(C4H4O4),2(C4H3O4)
Crystal Growth & Design (2013) 13, 8 3672
a=8.805(6)Å b=9.634(6)Å c=19.461(12)Å
α=88.035(11)° β=83.349(11)° γ=74.023(11)°
Olanzapinium p-aminobenzoate hemihydrate
C17H21N4S,C7H6NO2,O
Crystal Growth & Design (2013) 13, 8 3672
a=12.5118(10)Å b=9.6552(8)Å c=19.3403(16)Å
α=90.00° β=91.0660(10)° γ=90.00°
Olanzapine acetonitrile monohydrate
C17H20N4S,O
Crystal Growth & Design (2013) 13, 8 3672
a=24.549(2)Å b=12.5131(11)Å c=15.1433(13)Å
α=90.00° β=125.4670(10)° γ=90.00°
Olanzapine nitromethane monohydrate
C17H20N4S,O
Crystal Growth & Design (2013) 13, 8 3672
a=24.850(4)Å b=12.4355(17)Å c=15.128(2)Å
α=90.00° β=125.521(2)° γ=90.00°
Olanzapine ethanol monohydrate
C17H20N4S,0.5(C2O),H2O
Crystal Growth & Design (2013) 13, 8 3672
a=24.541(7)Å b=12.459(3)Å c=15.178(4)Å
α=90.00° β=125.485(4)° γ=90.00°
Olanzapine acetone monohydrate
C17H20N4S,0.5(C3H6O),H2O
Crystal Growth & Design (2013) 13, 8 3672
a=24.628(3)Å b=12.5833(15)Å c=15.2002(18)Å
α=90.00° β=125.803(2)° γ=90.00°
C27H23N5O14Tb2
C27H23N5O14Tb2
CrystEngComm (2014) 16, 24 5244
a=8.5085(4)Å b=16.0156(8)Å c=27.9393(14)Å
α=90° β=90° γ=90°